Filter by
 

Type of content

Publication date

Main subject

Main subject

Keywords

Keywords

Target audience

Search tool

Displaying 1 - 10 of 10

News

25 years of monitoring and responding to new drugs in Europe — update published today

14.06.2022

This year, the EU Early Warning System (EWS) on new psychoactive substances (NPS) celebrates its 25th anniversary.

News

Drug supply and use bounce back after COVID-19 disruption

14.06.2022

The rapid bounce back of drug supply and use following COVID-19 disruption is among the issues highlighted today by the EU drugs agency (EMCDDA) as it launches its European Drug Report 2022: Trends and Developments (

News

New report highlights public health and social risks posed by synthetic cannabinoids in Europe

09.09.2021

Synthetic cannabinoids come under the spotlight today in a new report released by the EU drugs agency (EMCDDA).

News

European Commission proposes to control two harmful new psychoactive substances

12.03.2021

Today, the European Commission has proposed to control two harmful new psychoactive substances (NPS) across the European Union. The substances in question — MDMB-4en-PINACA and 4F-MDMB-BICA — are both synthetic cannabinoids, which have been raising health concerns in Europe (1).

News

New report highlights wide-ranging impacts of EU drug markets on health and security

26.11.2019

Europeans are spending at least EUR 30 billion on drugs each year at retail level, making the drug market a major source of income for organised crime groups in the European Union.

News

EMCDDA publishes latest insights into NPS in Europe

07.06.2018

In a new update from the EU Early Warning System (EWS) on new psychoactive substances (NPS) (1), the EMCDDA releases today its latest insights in this area entitled Fentanils and synthetic c

News

Two new synthetic cannabinoids to be placed under control across the EU

14.05.2018

Today the European Union has decided to subject two new synthetic cannabinoids to control measures across the 28 Member States. The substances in question are ADB-CHMINACA and CUMYL-4CN-BINACA, which have been raising health concerns in Europe.

News

MDMB-CHMICA to be placed under control across the EU

27.02.2017

MDMB-CHMICA is a synthetic cannabinoid and will be subject to ‘control measures’ throughout the EU.

News

New psychoactive substances: Commission proposes new ban and strengthens the EU's Early Warning System and risk assessment

31.08.2016

Today, the European Commission has proposed to subject the new psychoactive substance MDMB-CHMICA (sometimes referred to as ‘Black Mamba’) to control measures across the European Union.

News

New drugs detected in the EU at the rate of around one per week, say agencies

26.04.2012

New drugs were detected in the European Union last year at the rate of around one per week, according to the EMCDDA–Europol 2011 annual report on new psychoactive substances released today (1).
Loading